Ozempic works by mimicking a natural gut hormone called GLP-1, which your body releases after eating. The active ingredient, semaglutide, activates the same receptors as this hormone but lasts far longer in your system, helping control blood sugar, reduce appetite, and slow digestion. These overlapping effects make it effective for type 2 diabetes and, at higher doses under a different brand name, for weight loss.
The Hormone It Copies
When you eat, your intestines release GLP-1 (glucagon-like peptide-1), a hormone that tells your pancreas to produce insulin and signals your brain that you’re getting full. Natural GLP-1 breaks down within minutes. Semaglutide is engineered to resist that breakdown, giving it a half-life of about 160 hours, or roughly a week. That’s why Ozempic is a once-weekly injection rather than something you take with every meal.
Because semaglutide keeps GLP-1 receptors activated around the clock rather than for a few fleeting minutes, its effects on blood sugar, appetite, and digestion are far more pronounced than what natural GLP-1 alone could achieve.
How It Lowers Blood Sugar
Semaglutide increases insulin secretion in response to meals, which pulls sugar out of your bloodstream and into your cells. At the same time, it suppresses glucagon, a hormone that tells your liver to release stored sugar. The combined effect brings blood sugar down from both directions.
One important safety feature: this process is glucose-dependent. Semaglutide only boosts insulin when blood sugar is actually elevated. Injected insulin, by contrast, works regardless of your glucose level, which creates a real risk of blood sugar dropping too low. Semaglutide’s built-in safety switch makes dangerous hypoglycemia much less likely. In clinical trials (the SUSTAIN program), patients using semaglutide saw their HbA1c, a measure of average blood sugar over three months, drop by 1.4 to 1.8 percentage points. That’s a substantial improvement for most people with type 2 diabetes.
How It Reduces Appetite
The weight loss people experience on Ozempic isn’t just a side benefit of better blood sugar control. Semaglutide directly affects the brain’s appetite-regulating circuits. It activates GLP-1 receptors on neurons in a region called the area postrema, located in the brainstem, which serves as the drug’s main entry point into the brain. From there, a cascade of neural signals spreads to areas involved in hunger, satiety, and food reward.
The practical result is that people on semaglutide feel full sooner, think about food less often, and find it easier to stop eating. In the landmark STEP 1 trial, participants taking a higher dose of semaglutide (2.4 mg, marketed as Wegovy rather than Ozempic) lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% in the placebo group. Ozempic’s lower doses produce more modest weight loss, but the appetite suppression still plays a significant role for many users.
How It Slows Digestion
Semaglutide delays gastric emptying, meaning food sits in your stomach longer than it normally would. This contributes to the feeling of fullness after smaller meals and helps prevent the sharp blood sugar spikes that follow eating. The effect is strongest in the first few weeks of treatment and partially fades over time, though digestion doesn’t fully return to normal. After 16 weeks of continuous use, gastric emptying is still slower than in people not taking the drug.
This slowed digestion is also the main reason for the most common side effects. In clinical practice, about 28% of people experience nausea, 12% have vomiting, 10% report diarrhea, and 6% deal with constipation. These symptoms tend to be worst when you first start the medication or when your dose increases, then often improve as your body adjusts.
Cardiovascular Protection
Beyond blood sugar and weight, semaglutide appears to reduce cardiovascular risk through pathways researchers are still working to fully understand. Excess body fat, particularly the visceral fat around your organs, releases inflammatory compounds that damage blood vessels over time. Fat deposits around the heart and along blood vessels can cause direct local harm as well. Semaglutide helps reduce these fat stores, but the cardiovascular benefits observed in large trials like SELECT appear to go beyond weight loss alone. Participants saw reduced rates of heart attacks and strokes even when their weight loss was modest, suggesting the drug has protective effects on blood vessels and inflammation that operate independently of how many pounds you lose.
What Taking It Looks Like
Ozempic is a subcutaneous injection, meaning it goes just under the skin, typically in the abdomen, thigh, or upper arm. You take it once a week on the same day each week, at any time of day, with or without food.
The dosing follows a gradual ramp-up to minimize side effects. You start at 0.25 mg weekly for the first four weeks. This starting dose isn’t strong enough to meaningfully control blood sugar; it’s purely to let your body adjust. After four weeks, you move to 0.5 mg. If your blood sugar still needs more control after at least another four weeks, your dose can increase to 1 mg, which is the maximum for Ozempic. The whole titration process takes a minimum of eight weeks before reaching a full therapeutic dose.
Because semaglutide has such a long half-life, it takes about five weeks after your last injection for the drug to fully clear your system. This means side effects, both wanted and unwanted, don’t disappear overnight if you stop taking it.